About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Chicago | 17,802 Studies Near You

Clinical TrialsChicago

Clinical Trials in Chicago

Discover 17,802 clinical trials near Chicago, Illinois. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 7141-7160 of 17,802 trials

TerminatedTesting the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast CancerThis randomized phase III trial studies how well paclitaxel, trastuzumab, and pertuzumab with or without atezolizumab works in treating patients with breast cancer that has spread…NCT03199885·Birmingham, Alabama and 672 others

Find Trials by Condition in Chicago

Breast Cancerin Chicago Lung Cancerin Chicago Prostate Cancerin Chicago Colorectal Cancerin Chicago Melanomain Chicago Leukemiain Chicago Lymphomain Chicago Pancreatic Cancerin Chicago Ovarian Cancerin Chicago Brain Cancerin Chicago Diabetes

Data from ClinicalTrials.govTerms

CompletedEfficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and APMeropenem-vaborbactam is being compared to piperacillin-tazobactam in the treatment of adults with complicated urinary tract infection (cUTI) or acute pyelonephritis (AP).NCT02166476·Mobile, Alabama and 76 others

TerminatedComparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal VaricesThis study evaluates the safety and efficacy of 24-hour vs 72-hour octreotide infusion after variceal banding in cirrhotic patients with bleeding esophageal varices.NCT03624517·Jacksonville, Florida and 7 others

CompletedTrial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 InhibitionPatients with chronic kidney disease, who have evidence of systemic inflammation with increased cardiovascular risk, will be enrolled into this trial.NCT03926117·Birmingham, Alabama and 48 others

CompletedEfficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in AdultsMulticenter, phase III, randomized, blinded, controlled, parallel group with safety extension phase with crossover or continued treatment.NCT05219968·Birmingham, Alabama and 54 others

RecruitingRuxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate CancerThis phase I/II tests the safety, side effects and best dose of ruxolitinib in combination with enzalutamide and how well it works in treating patients with prostate cancer that…NCT06616155·Chicago, Illinois and 2 others

No longer availableExpanded Treatment Protocol With LDK378 in ALK(+) NSCLCNovartis-sponsored, open-label, multi-center, interventional ETP to provide LDK378 to patients with ALK (+)NSCLC, who have been pre-treated with an ALK inhibitor; except in…NCT01947608·Chandler, Arizona and 49 others

CompletedBortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple MyelomaThis phase II trial studies the side effects and how well bortezomib and pegylated liposomal doxorubicin hydrochloride work in treating patients multiple myeloma that are…NCT00088855·Mountain View, California and 24 others

CompletedCP-675,206 In Patients With Advanced MelanomaThe purpose of this study is to assess the efficacy, safety, and tolerability of monoclonal antibody therapy using 2 regimens for the treatment of advanced melanomaNCT00086489·Los Angeles, California and 8 others

CompletedIslatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)This study will evaluate the safety, tolerability, antiretroviral activity, and pharmacokinetics of 3 doses of islatravir (MK-8591) in combination with doravirine (DOR) and…NCT03272347·Phoenix, Arizona and 25 others

CompletedPrialt (Ziconotide) In Severe Chronic PainThe purpose of this study is to understand the effects of intrathecal ziconotide (an experimental pain medication) when the dose is slowly increased over a 3-week period in…NCT00047749·Huntsville, Alabama and 43 others

CompletedHIV Prevention Intervention for Young Transgender WomenThe purpose of this study is to test the efficacy of a uniquely targeted HIV risk reduction intervention for young transgender women (YTW), ages 16 to 29, at risk for HIV…NCT01575938·Chicago, Illinois and 1 other

CompletedMulti-center Study to Transplant Hepatitis-C Infected KidneysOpen label multi center study for the donation of HCV positive kidneys to HCV negative recipients with interventional treatment to prevent HCV transmission upon transplantation.NCT03781726·Chicago, Illinois and 6 others

CompletedA Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant TreatmentThe current study will evaluate the antidepressant effect of CERC-301 during 28 days of treatment in subjects with MDD who are currently experiencing a severe depressive episode…NCT01941043·Birmingham, Alabama and 23 others

WithdrawnTrauma-Focused Intervention With Women Experiencing HomelessnessHomelessness and associated traumas disproportionately affect women. The biopsychosocial health consequences of untreated trauma are profound.NCT05873517·Chicago, Illinois and 1 other

CompletedTreatment of Peripheral Arterial Hemorrhage With Lava LES (The LAVA Study)To evaluate the safety and effectiveness of the Lava LES for the embolic treatment of arterial hemorrhage in the peripheral vasculature.NCT04649255·Irvine, California and 8 others

CompletedLong-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)Cystinosis is an inherited disease that if untreated, results in kidney failure as early as the first decade of life.NCT01197378·San Francisco, California and 9 others

CompletedSafety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery LesionsThe objective of this post-approval study is to confirm that the clinical performance of the Orsiro stent in a real-world setting is similar to the clinical performance observed…NCT04175626·Fairhope, Alabama and 32 others

CompletedKALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 WeeksThis study will compare the ability of fosamprenavir 700 mg with ritonavir 100 mg twice a day or lopinavir 400 mg with ritonavir 100 mg twice a day both combined with a fixed dose…NCT00085943·Birmingham, Alabama and 118 others

CompletedPeanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)The purpose of this study is to demonstrate the efficacy and safety of AR101 through reduction in clinical reactivity to peanut allergen in peanut-allergic children and adults.NCT02635776·Tucson, Arizona and 68 others

PreviousPage 358 of 891Next

in Chicago

Heart Diseasein Chicago